[EN] NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS<br/>[FR] NOUVEAUC DERIVES ALKYNYL SERVANT DE MODULATEURS DE RECEPTEURS DE GLUTAMATE METABOTROPIQUES
                        
                            
                                申请人:ADDEX PHARMACEUTICALS SA
                            
                            
                                公开号:WO2005123703A2
                            
                            
                                公开(公告)日:2005-12-29
                            
                            The present invention relates to novel compounds of formula (I) wherein W, n, X and W’ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors - subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.